4/A//SEC Filing
Dissanaike Sharmila 4/A
Accession 0000950170-25-013770
CIK 0000818033other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 5:34 PM ET
Size
7.1 KB
Accession
0000950170-25-013770
Insider Transaction Report
Form 4/AAmended
Dissanaike Sharmila
Director
Transactions
- Award
Common Stock
2025-01-31+17,950→ 87,180 total - Award
Stock Option (Right to Buy)
2025-01-31+35,900→ 35,900 totalExercise: $1.70Exp: 2035-01-31→ Common Stock (35,900 underlying)
Footnotes (2)
- [F1]The shares were granted as restricted stock units which vest in full on January 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant.
Documents
Issuer
HERON THERAPEUTICS, INC. /DE/
CIK 0000818033
Entity typeother
Related Parties
1- filerCIK 0001885069
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 5:34 PM ET
- Size
- 7.1 KB